Skip to main content
Clinical Trials/ISRCTN16783092
ISRCTN16783092
Completed
未知

A feasibility trial of the effects of home-based alpha frequency neurofeedback in modulating cortical activity and alleviating motor symptoms in Parkinson’s disease

Betsi Cadwaladr University Health Board0 sites16 target enrollmentAugust 29, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Parkinson's Disease
Sponsor
Betsi Cadwaladr University Health Board
Enrollment
16
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Registry
who.int
Start Date
August 29, 2017
End Date
August 30, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Idiopathic PD diagnosed using the UK Brain Bank Diagnostic Criteria
  • 2\. Hoehn and Yahr stage 1\-3 (Hoehn and Yahr, 1967; Bhidayasiri and Tarsy, 2012\)
  • 3\. On stable treatment for the last one month and no planned changes over the period of the study
  • 4\. Ability to give informed consent
  • 5\. Aged 18 years and over

Exclusion Criteria

  • 1\. Clinical diagnosis of dementia
  • 2\. Active psychosis, clinically significant depression or behavioural disturbance
  • 3\. Presence of another neurological condition
  • 4\. Active adjustment of medication during the predicted study period
  • 5\. Inability to give informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials